A randomized clinical trial evaluating Hydralazine’s efficacy in early-stage Alzheimer’s disease: The EHSAN Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A randomized clinical trial evaluating Hydralazine’s efficacy in early-stage Alzheimer’s disease: The EHSAN Study ; volume:14 ; number:1 ; day:21 ; month:11 ; year:2024 ; pages:1-13 ; date:12.2024
Scientific reports ; 14, Heft 1 (21.11.2024), 1-13, 12.2024
- Urheber
-
Mirzaei, Masoud
Ahmadi, Nastaran
Bagheri Fahraji, Behnam
Ardekani, Ali Mellat
Rahimdel, Abolghasem
Soltani, Mohammad Hossein
Ardekani, Seyed Mojtaba Yassini
Bidaki, Reza
Kasnavie, Fatemeh Hosseini
Dastjerdi, Ghasem
Aboutorabi, Marzieh
Mirzaei, Hamid
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-79616-4
- URN
-
urn:nbn:de:101:1-2502072129326.076134906387
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mirzaei, Masoud
- Ahmadi, Nastaran
- Bagheri Fahraji, Behnam
- Ardekani, Ali Mellat
- Rahimdel, Abolghasem
- Soltani, Mohammad Hossein
- Ardekani, Seyed Mojtaba Yassini
- Bidaki, Reza
- Kasnavie, Fatemeh Hosseini
- Dastjerdi, Ghasem
- Aboutorabi, Marzieh
- Mirzaei, Hamid
- SpringerLink (Online service)
Ähnliche Objekte (12)
Automated detection of early-stage Alzheimer’s Disease
Properties of odor identification testing in screening for early-stage Alzheimer’s disease
Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
Reach-to-grasp kinematics and kinetics with and without visual feedback in early-stage Alzheimer’s disease
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
Isoflurane has no effect on cognitive or behavioral performance in a mouse model of early-stage Alzheimer’s disease
Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer’s Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model
Automated detection of early-stage Alzheimer’s Disease
Properties of odor identification testing in screening for early-stage Alzheimer’s disease
Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
Reach-to-grasp kinematics and kinetics with and without visual feedback in early-stage Alzheimer’s disease
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
Isoflurane has no effect on cognitive or behavioral performance in a mouse model of early-stage Alzheimer’s disease
Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer’s Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model
Automated detection of early-stage Alzheimer’s Disease
Properties of odor identification testing in screening for early-stage Alzheimer’s disease
Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
Reach-to-grasp kinematics and kinetics with and without visual feedback in early-stage Alzheimer’s disease
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
Isoflurane has no effect on cognitive or behavioral performance in a mouse model of early-stage Alzheimer’s disease
Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer’s Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits